These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7211707)

  • 41. Increased exercise tolerance with nitrates in beta-blockaded patients with angina.
    Baxter RH; Lennox IM
    Br Med J; 1977 Aug; 2(6086):550-2. PubMed ID: 19122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
    Stauch M; Grewe N
    Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
    Thadani U; Bittar N
    Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
    Kokurina EV; Bochkareva EV; Martsevich SIu; Shakarova SSh; Vygodin VA
    Kardiologiia; 1985 Apr; 25(4):35-40. PubMed ID: 4021271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.
    Whittington J; Raftery EB
    Br J Clin Pharmacol; 1980 Sep; 10(3):211-5. PubMed ID: 7002181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 47. The long-acting hemodynamic effects of isosorbide dinitrate.
    Sweatman T; Strauss G; Selzer A; Cohn KE
    Am J Cardiol; 1972 Apr; 29(4):475-80. PubMed ID: 4622753
    [No Abstract]   [Full Text] [Related]  

  • 48. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
    Thadani U; Jacob RG
    Drugs Today (Barc); 2008 Dec; 44(12):925-37. PubMed ID: 19198701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of propranolol and of isosorbide dinitrate in angina pectoris.
    Aronow WS; Kaplan MA
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):80-6. PubMed ID: 4975818
    [No Abstract]   [Full Text] [Related]  

  • 50. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Eisenberger AB
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761995
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of placebo, nitroglycerin, and isosorbide dinitrate for effectiveness of relief of angina and duration of action.
    Kattus AA; Alvaro AB; Zohman LR; Coulson AH
    Chest; 1979 Jan; 75(1):17-23. PubMed ID: 105834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Withdrawal effects of antianginal therapy: comparison of isosorbide dinitrate and nifedipine.
    Martsevich SYu ; Koutishenko N; Metelitsa VI
    Int J Cardiol; 1998 Apr; 64(2):137-44. PubMed ID: 9688432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The rational basis of the beta blockader-nitroderivative combination in the treatment of late postinfarction angina].
    Pasotti C; Vibelli C; Capra A
    Minerva Cardioangiol; 1978 Mar; 26(3):193-6. PubMed ID: 652155
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure.
    Wilson JR; Untereker W; Hirshfeld J
    Am J Cardiol; 1981 Nov; 48(5):934-8. PubMed ID: 7304441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
    Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
    Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
    Figini A; De Ponti C; Campolo L
    G Ital Cardiol; 1974; 4(3):289-95. PubMed ID: 4152383
    [No Abstract]   [Full Text] [Related]  

  • 59. [Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort].
    Belenkov IuN; Ageev FT; Nuraliev EIu; Prostakova TS; Dzhakhangirov TSh
    Kardiologiia; 2005; 45(9):11-5. PubMed ID: 16234785
    [No Abstract]   [Full Text] [Related]  

  • 60. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.